Amber LaCrosse

511 total citations
14 papers, 422 citations indexed

About

Amber LaCrosse is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Social Psychology. According to data from OpenAlex, Amber LaCrosse has authored 14 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 2 papers in Social Psychology. Recurrent topics in Amber LaCrosse's work include Neuroscience and Neuropharmacology Research (10 papers), Receptor Mechanisms and Signaling (6 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Amber LaCrosse is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Receptor Mechanisms and Signaling (6 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Amber LaCrosse collaborates with scholars based in United States. Amber LaCrosse's co-authors include M. Foster Olive, Lori A. Knackstedt, Natali E. Nemirovsky, Kristine Hill, Tuan Q. Le, Andrew F. Scheyer, Edén Flores-Barrera, Marina E. Wolf, Kerstin A. Ford and Craig Werner and has published in prestigious journals such as Journal of Neuroscience, Nature Neuroscience and Neuroscience.

In The Last Decade

Amber LaCrosse

13 papers receiving 419 citations

Peers

Amber LaCrosse

CMN

Maxime Fouyssac United Kingdom

Russell S. Dulman United States

Sean Durkin Switzerland

Ratnamala Pavuluri United States

Claudia Rangel‐Barajas United States

Joanna Ekström Sweden

Rebecca S. Benham United States

Vorani Ramachandra United States

Claire I. Dixon United Kingdom

Richard M. Cleva United States

Maxime Fouyssac United Kingdom

Amber LaCrosse

274 ×0.8

CMN

122 ×0.6

73 ×0.8

44 ×1.1

38 ×1.0

Citations per year, relative to Amber LaCrosse Amber LaCrosse (= 1×) peers Maxime Fouyssac

Countries citing papers authored by Amber LaCrosse

Since Specialization

Citations

This map shows the geographic impact of Amber LaCrosse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber LaCrosse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber LaCrosse more than expected).

Fields of papers citing papers by Amber LaCrosse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amber LaCrosse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber LaCrosse. The network helps show where Amber LaCrosse may publish in the future.

Co-authorship network of co-authors of Amber LaCrosse

This figure shows the co-authorship network connecting the top 25 collaborators of Amber LaCrosse. A scholar is included among the top collaborators of Amber LaCrosse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amber LaCrosse. Amber LaCrosse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Hoffmann, Jan, et al.. (2024). Efficacy of fluoxetine and (R,S)-ketamine in attenuating conditioned fear behaviors in male mice. Journal of Pharmacology and Experimental Therapeutics. 392(1). 100028–100028.

LaCrosse, Amber, Christina E. May, William C. Griffin, & M. Foster Olive. (2024). mGluR5 positive allosteric modulation prevents MK-801 induced increases in extracellular glutamate in the rat medial prefrontal cortex. Neuroscience. 555. 83–91. 4 indexed citations

LaCrosse, Amber, et al.. (2018). Nucleus accumbens GLT-1a overexpression reduces glutamate efflux during reinstatement of cocaine-seeking but is not sufficient to attenuate reinstatement. Neuropharmacology. 135. 297–307. 20 indexed citations

Bechard, Allison R., et al.. (2018). Impairments in reversal learning following short access to cocaine self-administration. Drug and Alcohol Dependence. 192. 239–244. 8 indexed citations

LaCrosse, Amber, Sinead M. O’Donovan, Marian T. Sepulveda-Orengo, et al.. (2017). Contrasting the Role of xCT and GLT-1 Upregulation in the Ability of Ceftriaxone to Attenuate the Cue-Induced Reinstatement of Cocaine Seeking and Normalize AMPA Receptor Subunit Expression. Journal of Neuroscience. 37(24). 5809–5821. 57 indexed citations

LaCrosse, Amber, et al.. (2017). Generation of a Patient-Derived Brain Metastasis Breast Cancer Cell Line via Novel Orthotopic Injection Placement and Serial Mouse Transplantation to Develop PDX Mouse Model. Journal of patient-centered research and reviews. 4(4). 257–257. 1 indexed citations

LaCrosse, Amber, Kristine Hill, & Lori A. Knackstedt. (2015). Ceftriaxone attenuates cocaine relapse after abstinence through modulation of nucleus accumbens AMPA subunit expression. European Neuropsychopharmacology. 26(2). 186–194. 44 indexed citations

LaCrosse, Amber, Sara B. Taylor, Natali E. Nemirovsky, Justin T. Gass, & M. Foster Olive. (2015). mGluR5 Positive and Negative Allosteric Modulators Differentially Affect Dendritic Spine Density and Morphology in the Prefrontal Cortex. CNS & Neurological Disorders - Drug Targets. 14(4). 476–485. 13 indexed citations

LaCrosse, Amber, et al.. (2014). mGluR5 positive allosteric modulation and its effects on MK-801 induced set-shifting impairments in a rat operant delayed matching/non-matching-to-sample task. Psychopharmacology. 232(1). 251–258. 19 indexed citations

10.

Loweth, Jessica A., Andrew F. Scheyer, Mike Milovanovic, et al.. (2013). Synaptic depression via mGluR1 positive allosteric modulation suppresses cue-induced cocaine craving. Nature Neuroscience. 17(1). 73–80. 136 indexed citations

11.

LaCrosse, Amber & M. Foster Olive. (2013). Neuropeptide Systems and Schizophrenia. CNS & Neurological Disorders - Drug Targets. 12(5). 619–632. 34 indexed citations

12.

Prus, Adam J., Todd M. Hillhouse, & Amber LaCrosse. (2013). Acute, but not repeated, administration of the neurotensin NTS1 receptor agonist PD149163 decreases conditioned footshock-induced ultrasonic vocalizations in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 49. 78–84. 27 indexed citations

13.

LaCrosse, Amber, et al.. (2013). NMDA Receptor Modulators in the Treatment of Drug Addiction. Pharmaceuticals. 6(2). 251–268. 55 indexed citations

14.

Hicks, Megan P., et al.. (2012). Increases in Doublecortin Immunoreactivity in the Dentate Gyrus following Extinction of Heroin-Seeking Behavior. Neural Plasticity. 2012. 1–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact